Hoi Shuen Solina Holly Chau

Hoi Shuen Solina Holly Chau, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Celsius Holdings, Inc. and Niagen Bioscience, Inc. The record holds 7 filings, for trades running from 16 June 2022 to 20 August 2024.

On the open market, the record shows 3 purchases worth €1.3M and 4 sales worth €186.7M. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2024 alone, the filings show 1 purchase and no sales.

Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 21 August 2024, the filings show an open-market purchase in Niagen Bioscience, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.